SMTL ID : 6huj.1

CryoEM structure of human full-length heteromeric alpha1beta3gamma2L GABA(A)R in complex with picrotoxin, GABA and megabody Mb38.

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-2-2-1-1-mer

Ligands

1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN.1: 8 residues within 4Å: Chain A: N.146, T.148 Chain B: K.137 Chain C: W.162, P.166 Chain D: K.141, K.152 Ligands: NAG-NAG-BMA-MAN-MAN.5 No protein-ligand interaction detected (PLIP)

2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN.2: 9 residues within 4Å: Chain B: N.174, E.215, R.217, V.219, S.220, R.221, S.236, F.237, R.238 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:R.217, B:R.221 NAG-NAG-BMA-MAN-MAN-MAN.7: 9 residues within 4Å: Chain E: N.174, E.215, R.217, V.219, S.220, R.221, S.236, F.237, R.238 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:S.234

3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.3: 2 residues within 4Å: Chain B: N.105, H.144 No protein-ligand interaction detected (PLIP) NAG-NAG.4: 3 residues within 4Å: Chain C: R.224, S.226, N.247 No protein-ligand interaction detected (PLIP) NAG-NAG.6: 2 residues within 4Å: Chain E: N.105, H.144 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.5: 10 residues within 4Å: Chain A: L.124, S.127 Chain D: N.146, T.148, M.149, P.150 Chain E: D.114, Q.115 Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.1, NAG-NAG-BMA-MAN-MAN-MAN-MAN.1 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:Q.115, E:D.114

2 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)

PIO.8: 10 residues within 4Å: Chain A: R.284, T.341, F.345, R.348, N.422, S.423, S.425, K.426, I.427, L.430 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:T.341, A:L.430 Hydrogen bonds: A:R.284, A:R.284, A:F.345, A:S.423, A:S.425, A:S.425, A:K.426 Salt bridges: A:R.284, A:R.348 PIO.11: 11 residues within 4Å: Chain D: R.284, T.341, F.345, K.347, R.348, N.422, S.423, S.425, K.426, I.427, L.430 11 PLIP interactions: 11 interactions with chain D Hydrophobic interactions: D:T.341, D:I.427 Hydrogen bonds: D:R.284, D:R.284, D:F.345, D:S.423, D:K.426 Salt bridges: D:R.284, D:K.347, D:K.347, D:R.348

1 x RI5: (1aR,2aR,3S,6R,6aS,8aS,8bR,9R)-2a-hydroxy-8b-methyl-9-(prop-1-en-2-yl)hexahydro-3,6-methano-1,5,7-trioxacyclopenta[ij]c yclopropa[a]azulene-4,8(3H)-dione(Non-covalent)

RI5.9: 14 residues within 4Å: Chain A: V.292, T.296 Chain B: A.277, I.280, T.281 Chain C: S.306, T.310, L.313 Chain D: V.292, T.296, L.299 Chain E: A.277, T.281, L.284 7 PLIP interactions: 2 interactions with chain E, 1 interactions with chain A, 3 interactions with chain D, 1 interactions with chain C Hydrophobic interactions: E:T.281, E:L.284, D:V.292, D:T.296, D:L.299, C:L.313 Hydrogen bonds: A:T.296

2 x ABU: GAMMA-AMINO-BUTANOIC ACID(Non-covalent)

ABU.10: 9 residues within 4Å: Chain A: F.100, R.102, T.165 Chain B: Y.122, E.180, S.181, Y.182, T.227, Y.230 6 PLIP interactions: 2 interactions with chain B, 4 interactions with chain A Hydrophobic interactions: B:Y.230, A:F.100, A:F.100 Hydrogen bonds: B:S.181, A:T.165 Salt bridges: A:R.102 ABU.12: 9 residues within 4Å: Chain D: F.100, R.102, T.165 Chain E: Y.122, E.180, S.181, Y.182, T.227, Y.230 5 PLIP interactions: 3 interactions with chain D, 2 interactions with chain E Hydrophobic interactions: D:F.100, E:Y.230 Hydrogen bonds: D:T.165, E:S.181 Salt bridges: D:R.102

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Masiulis, S. et al., GABAAreceptor signalling mechanisms revealed by structural pharmacology. Nature (2019)

Release Date

2019-01-02

Peptides

Gamma-aminobutyric acid receptor subunit alpha-1,Gamma-aminobutyric acid receptor subunit alpha-1: AD
Gamma-aminobutyric acid receptor subunit beta-3: BE
Gamma-aminobutyric acid receptor subunit gamma-2: C
Megabody Mb38: F

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

D
D

B
B

E
E

C
C

F
G

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Gamma-aminobutyric acid receptor subunit alpha-1,Gamma-aminobutyric acid receptor subunit alpha-1

Gamma-aminobutyric acid receptor subunit beta-3

Gamma-aminobutyric acid receptor subunit gamma-2

Megabody Mb38

Related Entries With Identical Sequence